Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091

Go back to Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
(NASDAQ: BNR) Delayed: 18.35 -0.39 (2.08%)
Previous Close $18.74    52 Week High
Open $18.93    52 Week Low
Day High $19.08    P/E N/A 
Day Low $17.91    EPS
Volume 386,508